Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Oct;13(5):241-243.
doi: 10.14740/wjon1535. Epub 2022 Oct 22.

The Dimensions of Reports From Around the World That Address Diversity in Oncology

Kazuaki Takabe  1 , Vidalina Day  1 , Matthew G K Benesch  1
Affiliations
Editorial

The Dimensions of Reports From Around the World That Address Diversity in Oncology

Kazuaki Takabe et al. World J Oncol. 2022 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

None of the authors has any conflict to any entity in regard to the content of this editorial.

Figures

Figure 1
Figure 1
The continents of origin of the articles published in the World Journal of Oncology. Dark blue illustrates the ratio from the Americas, orange from Europe, gray from Africa, yellow from Asia, and light blue from Oceania, respectively.
Figure 2
Figure 2
Numbers of articles published in the World Journal of Oncology (2010 - 2022) from each country: USA 178, Japan 53, India 43, China 22, Canada 20, Turkey 18, UK 17, Italy 16, Australia 14, Tunisia 10, Mexico 9, Brazil 9, Egypt 8, Greece 7, Saudi Arabia 6, France 5, Germany 5, Spain 5, Taiwan 5, Portugal 4, Nepal 4, Thailand 4, Sweden 3, Morocco 3, Nigeria 3, Jordan 3, Israel 3, Ireland 2, Austria 2, Kosovo 2, Iran 2, Pakistan 2, Malaysia 2, Indonesia 2, West Indies 1, Argentina 1, Russia 1, Belarus 1, Czechia 1, Croatia 1, Albania 1, Senegal 1, Liberia 1, Sudan 1, Lebanon 1, Iraq 1, UAE 1, Bangladesh 1, Korea 1, Vietnam 1, Singapore 1, Philippines 1, respectively. UAE: United Arab Emirates.
See this image and copyright information in PMC

References

    1. Yedjou CG, Sims JN, Miele L, Noubissi F, Lowe L, Fonseca DD, Alo RA. et al. Health and racial disparity in breast cancer. Adv Exp Med Biol. 2019;1152:31–49. doi: 10.1007/978-3-030-20301-6_3. - DOI - PMC - PubMed
    1. Mok TS, Wu YL, Thongprasert S, Yang CH, Chu DT, Saijo N, Sunpaweravong P. et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med. 2009;361(10):947–957. doi: 10.1056/NEJMoa0810699. - DOI - PubMed
    1. Douillard JY, Ostoros G, Cobo M, Ciuleanu T, McCormack R, Webster A, Milenkova T. First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study. Br J Cancer. 2014;110(1):55–62. doi: 10.1038/bjc.2013.721. - DOI - PMC - PubMed
    1. Kudoh S, Kato H, Nishiwaki Y, Fukuoka M, Nakata K, Ichinose Y, Tsuboi M. et al. Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study. Am J Respir Crit Care Med. 2008;177(12):1348–1357. doi: 10.1164/rccm.200710-1501OC. - DOI - PubMed
    1. Beom SH, Kim DW, Sim SH, Keam B, Park JH, Lee JO, Kim TM. et al. Gefitinib-induced interstitial lung disease in korean lung cancer patients. Cancer Res Treat. 2016;48(1):88–97. doi: 10.4143/crt.2014.201. - DOI - PMC - PubMed

Publication types

LinkOut - more resources